Pill Might Extend Survival Among Kids With Rare Bone Cancer

Kids with a rare bone cancer might live longer if prescribed a drug that blocks blood supply to tumors, researchers say.

The drug pazopanib (Votrient) extended the lives of a small group of kids with Ewing sarcoma, which causes cancerous tumors in their bones, researchers report in the journal Frontiers in Oncology.

“W...

Millions Left Out as Hospital Portals Lack Multiple Language Options

Patient portals have made it easier for millions of Americans to view test results, message their doctors and schedule virtual visits. But for the more than 25 million people in the U.S. who speak little English, these tools often remain out of reach.

A University of Michigan study published Oct. 16 in JAMA Network Open found that...

Over 6 Million Eggs Recalled After Salmonella Found, FDA Warns

More than 6 million eggs sold under the Black Sheep Egg Company brand have been recalled after federal officials detected multiple strains of salmonella at one of its processing facilities.

The U.S. Food and Drug Administration (FDA) announced the recall after 40 environmental samples tested positive for salmonella, including seven strains...

Seaweed May Help Grow Human Tissue, Replacing Animal Testing

Scientists have found an unlikely new material for growing tissue: Seaweed.

The ocean plant, best known for wrapping sushi or floating along the shore, may soon help doctors repair hearts and reduce animal testing.

In a study published Oct. 21 in Biointerphases, researchers from Oregon State University in Corvallis found tha...

FDA and Kenvue Say No Autism Link to Tylenol Use During Pregnancy

The maker of Tylenol is urging U.S. health regulators not to add an autism warning label to it and other pain-relievers containing acetaminophen, calling the request “unsupported by the scientific evidence and legally and procedurally improper."

Kenvue’s response, dated Oct. 17, came after a citizen petition sought new pregnanc...

Drug Combo Cuts Death Risk From Advanced Prostate Cancer

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer.

Adding the drug enzalutamide to standard hormone therapy reduced the risk of premature death by more than 40% in patients whose prostate cancer had returned, a large international clinical trial has found.

The findings w...